title: Surgery and hormonal treatment for prostate cancer and sexual function.
abstract: Prostate cancer (PC) is one of the most common cancers effecting men today. With earlier detection and improvements in available treatment modalities, there still remains significant morbidity associated with the treatment of PC. Male sexual health and erectile function are greatly impacted by these therapies and remain a concern to PC survivors. This article reviews the current literature on male sexual health following radical prostatectomy (RP) or androgen ablation therapy for PC. Each treatment modality affects male sexual function to an appreciable level, although certain patients have better outcomes if they have preoperative potency, are younger, or have nerve-sparing surgery. There is a delayed recovery up to 2 years seen in erectile function following RP. With androgen deprivation therapy (ADT), attempts can be made at different administration strategies and exercise may possibly play a role in maintaining erectile function. Penile rehabilitation protocols attempt to protect erectile function immediately following therapy through different modalities, although no one approach has been agreed upon.
authors.affiliation: 1 Division of Urology, University of Texas Health Science Center, Houston, TX 77030, USA ; 2 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Katie
authors.initials: K
authors.lastname: Canalichio
authors.affiliation: 1 Division of Urology, University of Texas Health Science Center, Houston, TX 77030, USA ; 2 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Yasmeen
authors.initials: Y
authors.lastname: Jaber
authors.affiliation: 1 Division of Urology, University of Texas Health Science Center, Houston, TX 77030, USA ; 2 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Run
authors.initials: R
authors.lastname: Wang
keywords: Androgen deprivation; erectile dysfunction (ED); prostate cancer (PC); prostatectomy
references.citation: CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40
references.pmid: 4625049
references.citation: N Engl J Med. 2014 Sep 11;371(11):1067-9
references.pmid: 25184629
references.citation: J Sex Med. 2005 Jan;2(1):26-39
references.pmid: 16422902
references.citation: Urol Clin North Am. 2005 Nov;32(4):379-95, v
references.pmid: 16291031
references.citation: Eur Urol. 2014 Jan;65(1):58-65
references.pmid: 24007711
references.citation: Ann Intern Med. 2000 Apr 4;132(7):566-77
references.pmid: 10744594
references.citation: N Engl J Med. 2014 Mar 6;370(10):932-42
references.pmid: 24597866
references.citation: Radiother Oncol. 2012 Jul;104(1):96-102
references.pmid: 22682750
references.citation: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019
references.pmid: 17054269
references.citation: J Sex Med. 2010 Mar;7(3):1216-23
references.pmid: 19912504
references.citation: Curr Urol Rep. 2008 Nov;9(6):492-9
references.pmid: 18947515
references.citation: Ther Adv Urol. 2014 Feb;6(1):15-24
references.pmid: 24489605
references.citation: J Urol. 2002 Jul;168(1):9-12
references.pmid: 12050481
references.citation: Biochim Biophys Acta. 2014 Dec;1846(2):446-56
references.pmid: 25199985
references.citation: J Clin Oncol. 2004 Jul 1;22(13):2546-53
references.pmid: 15226323
references.citation: Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):603-16
references.pmid: 24054933
references.citation: JAMA. 2011 Sep 21;306(11):1205-14
references.pmid: 21934053
references.citation: Cancer. 2002 Jul 15;95(2):361-76
references.pmid: 12124837
references.citation: J Clin Oncol. 2012 Oct 20;30(30):3720-5
references.pmid: 23008326
references.citation: Urology. 2013 Jan;81(1):130-4
references.pmid: 23273077
references.citation: Eur Urol. 2014 Feb;65(2):467-79
references.pmid: 24321502
references.citation: BJU Int. 2006 May;97(5):963-8
references.pmid: 16542340
references.citation: J Sex Med. 2013 Mar;10(3):738-46
references.pmid: 23253086
references.citation: J Sex Med. 2011 Apr;8(4):1048-60
references.pmid: 21269401
references.citation: Prostate Cancer Prostatic Dis. 2013 Jun;16(2):170-5
references.pmid: 23318529
references.citation: Int J Endocrinol. 2014;2014:470592
references.pmid: 24744780
references.citation: Curr Urol Rep. 2014 Jul;15(7):420
references.pmid: 24844775
references.citation: Health Qual Life Outcomes. 2009 Nov 13;7:94
references.pmid: 19912640
references.citation: BJU Int. 2008 Jul;102(1):39-43
references.pmid: 18294309
references.citation: J Urol. 2007 Jan;177(1):128-30
references.pmid: 17162022
references.citation: Med J Aust. 2014 Jun 2;200(10):582-5
references.pmid: 24882489
references.citation: J Sex Med. 2007 Jul;4(4 Pt 2):1085-97
references.pmid: 17466058
references.citation: Eur Urol. 2014 Jan;65(1):124-37
references.pmid: 24207135
references.citation: Curr Opin Urol. 2014 Jul;24(4):401-6
references.pmid: 24809413
references.citation: Eur Urol. 2014 Mar;65(3):587-96
references.pmid: 24169081
references.citation: J Sex Med. 2011 Aug;8(8):2370-6
references.pmid: 21679306
references.citation: BJU Int. 2013 Jul;112(2):E169-76
references.pmid: 23253640
references.citation: J Urol. 2014 Jan;191(1):159-63
references.pmid: 24050893